Africa Molecular Diagnostics Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 375.96 Million |
| Market Size (2030) | USD 543.27 Million |
| CAGR (2025 - 2030) | 7.64% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Africa Molecular Diagnostics Market Analysis
The Africa Molecular Diagnostics Market size is estimated at USD 375.96 million in 2025, and is expected to reach USD 543.27 million by 2030, at a CAGR of 7.64% during the forecast period (2025-2030).
Some of the key factors driving the growth of the molecular diagnostics market in Africa include the growing demand for point-of-care diagnostics in the region, the growing burden of bacterial and viral diseases, and countries receiving funding from international organizations in the molecular diagnostics space.
The high disease burden in Africa creates a strong need for accurate and rapid diagnostics. For instance, an article published by Dove Press in July 2022 stated that, in sub-Saharan Africa (SSA), prevalence rates ranging from 14.7% to 82% were reported in countries like Nigeria, Gabon, Burkina Faso, Kenya, South Africa, and Tanzania. Children under the age of five have the highest risk of bacterial as well as viral infection in the region. Transmission is via the fecal route, either directly through person-to-person contact or indirectly through contaminated food and water. To cope with the rising burden of bacterial diseases, the region's diagnostic industry is taking steps that are expected to boost the demand for the molecular diagnostics market in Africa.
Furthermore, African countries are getting assistance from various organizations and associations, which is a beneficial factor in market growth. For instance, in July 2022, the World Bank approved a USD 100 million support program for the Africa Centre for Disease Control (Africa CDC) to enhance the institution’s technical capacity and strengthen its institutional framework to intensify support to African countries to prepare for detecting and responding to disease outbreaks and public health emergencies. With such funding from international organizations, the market for molecular diagnostics is expected to grow strongly during the forecast period.
Many African regions lack well-equipped healthcare facilities and trained personnel. There is a large gap between diagnostic needs and diagnostic access across much of sub-Saharan Africa (SSA), particularly for infectious diseases that inflict a substantial burden of morbidity. For instance, in an article published by PLOS Digital Health in June 2022, at least 50% of the population does not have access to essential health services. Advances in molecular diagnostics can accelerate healthcare provision toward Universal Health Coverage (UHC), bringing high-quality diagnostics and decision-support tools to the point of care. Hence, in the African region, many people lacking essential health services will further raise the need for molecular diagnostic services with the help of government initiatives anticipated to fuel the market's growth in the forecast period.
However, the high cost of disease diagnostics and the lack of trained healthcare professionals are expected to hamper the market growth in the coming years.
Africa Molecular Diagnostics Market Trends
Oncology Segment is Expected to Witness a Strong Growth During the Forecast Period
Key factors propelling the growth of the oncology segment include the rising burden of cancer in African countries, the growing reach of the companies in the region, and the rising focus on early disease diagnosis.
The rising burden of cancer is expected to fuel the segment's growth during the forecast period. For instance, according to the World Health Organization (WHO), in February 2023, approximately 1.1 million new cancer cases occurred each year in Africa. There is a considerable increase in cancer mortality to nearly one million deaths per year by 2030. The rising cases of cancer are augmenting the demand for early cancer screenings in the region, which is expected to boost the demand for molecular diagnostic products for cancer diagnosis.
Furthermore, there is a growing focus on various African initiatives in the cancer molecular diagnosis space, propelling the segment's growth. For instance, in August 2023, the Cancer Access Partnership, a collaboration between the African Cancer Coalition, the Clinton Health Access Initiative, and the American Cancer Society, was formed as a part of the cancer diagnosis initiative. Such initiatives are believed to contribute largely to the demand for molecular diagnostics for cancer detection, which is believed to propel the segment's growth over the forecast period.
South Africa is Expected to Hold a Significant Share of the Market
South Africa is the largest developing country in the African region. The country has witnessed a significant transformation in the past few years due to the rising focus of companies on investing in this developing economy.
The growing use of point-of-care diagnostics in South Africa and the rising burden of chronic diseases are expected to propel the demand for molecular diagnostics in the country. For instance, as per the data from the National Institute of Health published in July 2022, it was observed that the prevalence of HIV in the country was around 14.0% during the year 2022. Furthermore, it is estimated that over 7.9 million people in the country are affected with HIV currently. As HIV patients are more prone to various chronic and infectious diseases, the demand for molecular diagnostics products is expected to increase in the country during the forecast period.
Additionally, increasing product launches with advanced features are expected to drive the studied market. In January 2022, South African biotech startup BioCODE, headquartered in Cape Town, determined the rapid test of an individual's risk for developing early-stage cancer and cardiovascular diseases. The test was implemented during the year 2022.
Additionally, in November 2023, through Africa PGI 2.0, Africa CDC shifted its focus from emergency response to building an optimized, resilient, and integrated molecular diagnostic and genomic surveillance ecosystem. Also, Africa PGI 2.0 focuses on strengthening Africa's molecular diagnostic, genomics, and bioinformatics ecosystem. Hence, with the government's implementation of such tests and initiatives to focus on molecular diagnostics in the region, the market for molecular diagnostics is expected to grow in the coming years.
Africa Molecular Diagnostics Industry Overview
The molecular diagnostics market in Africa is moderately competitive in nature. This is mainly due to the rising investment of global companies in African countries, which show several growth opportunities. With the rising expansion strategies that the companies are implementing, it is expected that several small and mid-sized companies will penetrate the market and hold a substantial share in the future. The major players in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Thermo Fisher Scientific, and Nihon Kohden Corporation, among others.
Africa Molecular Diagnostics Market Leaders
-
Abbott Laboratories
-
F. Hoffmann-La Roche Ltd.
-
Siemens Healthineers
-
Thermo Fisher Scientific
-
Nihon Kohden Corporation
- *Disclaimer: Major Players sorted in no particular order
Africa Molecular Diagnostics Market News
• In December 2023: Alveo Technologies signed agreements to distribute its point-of-care molecular diagnostic products throughout Europe, Africa, and the Middle East. Alveo is developing tests for various infectious diseases, including influenza and respiratory syncytial virus, as well as for agricultural pathogens.
• In March 2022: Audere partnered with Medical Diagnostech, headquartered in South Africa, a developer and manufacturer of lateral flow rapid diagnostic test kits. This partnership will pair Medical Diagnostech’s MD SARS-nCoV-2 Antigen Device with Audere’s HealthPulse digital companion app.
Africa Molecular Diagnostics Industry Segmentation
As per the scope of the report, molecular diagnostic tests detect specific sequences in DNA or RNA (including single nucleotide polymorphisms (SNP), deletions, rearrangements, insertions, and others), which may or may not be associated with diseases. Molecular diagnostics has been revolutionized over the past few decades. Africa Molecular Diagnostics Market is segmented by technology, application, product, end user, and geography. The market is segmented by technology into in situ hybridization, chips and microarrays, mass spectrometry (MS), sequencing, PCR, and other technologies. The market is segmented by application into infectious disease, oncology, pharmacogenomics, microbiology, genetic disease screening, human leukocyte antigen typing, and blood screening. By product, the market is segmented into instruments, reagents, and other products. By end user, the market is segmented into hospitals, laboratories, and other end users. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.
| In Situ Hybridization |
| Chips and Microarrays |
| Mass Spectrometry (MS) |
| Sequencing |
| PCR |
| Other Technologies |
| Infectious Diseases |
| Oncology |
| Pharmacogenomics |
| Microbiology and Genetic Disease Screening |
| Human Leukocyte Antigen Typing |
| Blood Screening |
| Instruments |
| Reagents |
| Other Products |
| Hospitals |
| Laboratories |
| Other End Users |
| South Africa |
| Nigeria |
| Rest of Africa |
| By Technology | In Situ Hybridization |
| Chips and Microarrays | |
| Mass Spectrometry (MS) | |
| Sequencing | |
| PCR | |
| Other Technologies | |
| By Application | Infectious Diseases |
| Oncology | |
| Pharmacogenomics | |
| Microbiology and Genetic Disease Screening | |
| Human Leukocyte Antigen Typing | |
| Blood Screening | |
| By Product | Instruments |
| Reagents | |
| Other Products | |
| By End User | Hospitals |
| Laboratories | |
| Other End Users | |
| Geography | South Africa |
| Nigeria | |
| Rest of Africa |
Africa Molecular Diagnostics Market Research FAQs
How big is the Africa Molecular Diagnostics Market?
The Africa Molecular Diagnostics Market size is expected to reach USD 375.96 million in 2025 and grow at a CAGR of 7.64% to reach USD 543.27 million by 2030.
What is the current Africa Molecular Diagnostics Market size?
In 2025, the Africa Molecular Diagnostics Market size is expected to reach USD 375.96 million.
Who are the key players in Africa Molecular Diagnostics Market?
Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Thermo Fisher Scientific and Nihon Kohden Corporation are the major companies operating in the Africa Molecular Diagnostics Market.
Which is the fastest growing region in Africa Molecular Diagnostics Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Africa Molecular Diagnostics Market?
In 2025, the North America accounts for the largest market share in Africa Molecular Diagnostics Market.
What years does this Africa Molecular Diagnostics Market cover, and what was the market size in 2024?
In 2024, the Africa Molecular Diagnostics Market size was estimated at USD 347.24 million. The report covers the Africa Molecular Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Africa Molecular Diagnostics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
Africa Molecular Diagnostics Industry Report
Statistics for the 2025 Africa Molecular Diagnostics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Africa Molecular Diagnostics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
